• AAPL 169.01
  • TSLA 161.76
  • AMZN 177.02
  • MSFT 409.1175
  • INTC 34.7074
  • EURUSD 1.0705
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. MRUS.NASDAQ

Merus BV (MRUS NASDAQ) stock market data APIs

$40.89 0.07(0.2%) as of April 23, 2024

Merus BV Financial Data Overview

40.82
40.89
-
41.77
40.68
18.21-52.035
2 406 M
58 688 K
43 947 K
-1.04
1.105
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MRUS',
Type: 'Common Stock',
Name: 'Merus BV',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: 'NL0011606264',
CUSIP: 'N5749R100',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2016-05-19',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,
}

Merus BV Fundamental Data is available in our Financial Data APIs

  • Net Revenue 43 947 K
  • EBITDA -154 007 008
  • Earnings Per Share -3
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Merus BV Earnings via APIs

  • Latest Release 2024-02-28
  • EPS/Forecast -0.74

Get Merus BV End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Merus BV latest news via APIs

Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

Merus N.V. Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data selected for rapid oral session presentation MCLA-145 as monotherapy or in combination with pembro...

YmAbs Therapeutics (YMAB) Surges 8.2%: Is This an Indication of Further Gains?

Y-mAbs Therapeutics, Inc. (YMAB) shares rallied 8.2% in the last trading session to close at $14.89. This move can be attributable to notable volume with a higher number of shares being traded than in...
Do you have any questions?
support@eodhistoricaldata.com